1. MacDonald N, Mohsni E, Al-Mazrou Y, Kim Andrus
J, Arora N, Elden S, Madrid MY, et al. Global vaccine
action plan lessons learned I: Recommendations for
the next decade. Vaccine. 2020;38(33):5364-71.
2. Sarker AR, Akram R, Ali N, Chowdhury ZI, Sultana
M. Coverage and determinants of full immunization:
vaccination coverage among Senegalese children.
Medicina. 2019;55(8):480.
3. Hosseninasab A, Ebrahimpour M, Dehaghani A,
Noormandi MM. Evaluating the Immunogenicity of
the Pertussis Component of the DPT Vaccine in 12-
month old Infants in Kerman City, 2015. Health.
2017;6(3):228-35.
4. den Hartog G, van Binnendijk R, Buisman A-M,
Berbers GAM, van der Klis FRM. Immune
surveillance for vaccine-preventable diseases. Expert
Rev Vaccines. 2020;19(4):327-39.
5. Harder T, Takla A, Rehfuess E, Sánchez-Vivar A,
Matysiak-Klose D, Eckmanns T, et al. Evidence-
based decision-making in infectious diseases
epidemiology, prevention and control: matching
research questions to study designs and quality
appraisal tools. BMC Med Res Methodol. 2014;14:1-
16.
6. Hsu CC, Senussi NH, Fertrin KY, Kowdley KV. Iron
overload disorders. Hepatol Commun.
2022;6(8):1842-54.
7. Grady R, Akbar A, De Sousa M, et al. Transfusion-
related immunologic abnormalities in beta-
thalassemia major. Birth Defects Orig Artic Ser.
1987;23(5A):587-93.
8. Rotha KT, Toxicology. Iron Overload Complication
in Thalassemia Patients. Indian J Foren Med.
2020;14(2).
9. Zahira AF, Wasono ARP, Yudho SU, Kahar H. The
Role of Splenectomy in The Treatment of β-
Thalassemia Major Patients: A Literature Review.
The Role of Splenectomy in The Treatment of β-
Thalassemia Major Patients: A literature review. Int J
Res Pub. 2022;115(1): 441-6.
10. Venou T-M, Barmpageorgopoulou F, Peppa M,
Vlachaki E. Endocrinopathies in beta thalassemia: a
narrative review. Hormones. 2024;23(2):205-16.
11. Nokhodian Z, Ataei B, Zahraei SM, Gouya MM,
Hoseini SG, Yaran M, et al. Seroprevalence of
Bordetella pertussis among a nationally representative
sample of Iranian pediatric population: The childhood
and adolescence surveillance and prevention of adult
noncommunicable disease-V study. J Res Med Sci.
2021; 26(1):21.
12. Macina D, Evans KE. Pertussis in individuals with
co-morbidities: a systematic review. Infect Dis Ther.
2021;10 (3):1141-70.
13. Anwer R, Siddiq HM, Shahzadi S, Qureshi AM.
Systematic review of the incidence of transfusion-
transmitted infections in thalassemia patients
receiving multiple blood transfusions. J Life Social
Sci. 2025;3(3):49-56.
14. Khodaei GH, Farbod N, Zarif B, Nateghi S, Saeidi
M. Frequency of thalassemia in Iran and Khorasan
Razavi. Int J Pediatr. 2013;1(1):45-50.
15. Schrier SL. Pathophysiology of thalassemia. Curr
Opin Hematol. 2002;9(2):123-6.
16. Porto G, De Sousa M. Iron overload and immunity.
World J Gastroenterol. 2007;13(35):4707.
17. Rahav G, Volach V, Shapiro M, Rund D,
Rachmilewitz EA, Goldfarb A. Severe infections in
thalassaemic patients: prevalence and predisposing
factors. Br J Haematol. 2006;133(6):667-74.
18. Hasa E, Hartmann P, Schnabl B. Liver cirrhosis and
immune dysfunction. Int Immunol. 2022;34(9):455-
66.
19. Paul-Maria D, Johannes H, Ferenc R, Steinmann S.
Low antibody titers after second SARSCoV-2
vaccination in patients with autoimmune hepatitis. Z
Gastroenterol. 2022:e24-e.
20. Shamsizadeh A, Nikfar R, Bavarsadiankhah E,
Abbasi-Montazeri E, Neisi N, Arshadi M.
Identification of Etiological Agents of Pertussis-Like
Syndrome in Children Younger Than 5 Years Old
Hospitalized in Southwestern Iran. Jundishapur J
Microbiol. 2023;16(8).
21. Zahraei SM, Mohamadi P, Moradi G, Shirzadi S,
Azimian F, Khazaei Z, et al. Epidemiology incidence
and geographical distribution of Pertussis using GIS
and its incidence prediction in Iran in 2021. Med J
Islam Repub Iran. 2021;35:108.
22. Sedaghat M, Lotfi MN, Talebi M, aifi M, Pourshafie
MR. Status of pertussis in iran. Jundishapur J
Microbiol. 2014;7(11).
23. Hua CZ, He HQ, Shu Q. Resurgence of pertussis:
reasons and coping strategies. World J Pediatr.
2024:1-4.
24.Vakili R, Ghazizadeh Hashemi A, Khademi G,
Ajilian Abbasi M, Saeidi M. Immunization coverage
in WHO regions: a review article. J Pediatr Perspect.
2015;3(2.1):111-8.
25. Alimohamadi Y, Zahraei SM, Karami M, Yaseri M,
Lotfizad M, Holakouie-Naieni K. Alarm thresholds
for pertussis outbreaks in Iran: National data analysis.
Osong Public Health Res Perspect. 2020;11(5):309.
26. Noel G, Badmasti F, Nikbin VS, Zahraei SM, Madec
Y, Tavel D et al. Transversal sero-epidemiological
study of Bordetella pertussis in Tehran, Iran. PLoS
One. 2020;15(9):e0238398.
27. Zhu Y, Zhang W, Hu J, Luo S, Zhou Y, Tang X, et
al. Seroprevalence of IgG antibodies against pertussis
toxin in the Chinese population: A systematic review
and meta-analysis. Hum Vaccin. 2024;20(1):2341454.
28. Boey L, Bosmans E, Ferreira LB, Heyvaert N, Nelen
M, Smans L, et al. Seroprevalence of antibodies
against diphtheria, tetanus and pertussis in adult at-
risk patients. Vaccines. 2021;9(1):18.
29. Huang Z, Chen B, Liu X, Li H, Xie L, Gao Y, et al.
Effects of sex and aging on the immune cell landscape
as assessed by single-cell transcriptomic analysis.
Proc Natl Acad Sci U S A.
2021;118(33):e2023216118.
30. Eleftherianos I, Zhang W, Tettamanti G, Daley L,
Mohamed A, Stanley D. Nutrition influences
immunity: Diet and host-parasite interactions. Insect
Biochem Mol Biol. 2024;175:104210.
31. Kapil P, Merkel TJ. Pertussis vaccines and
protective immunity. Curr Opin Immunol.
2019;59:72-8.
32. Dhainaut J-F, Claessens Y-E, Janes J, Nelson DR.
Underlying disorders and their impact on the host
response to infection. Clin Infect Dis.
2005;41(Supplement_7):S481-S9.
33. Aggeletopoulou I, Davoulou P, Konstantakis C,
Thomopoulos K, Triantos C. Response to hepatitis B
vaccination in patients with liver cirrhosis. Rev Med
Virol. 2017;27(6):e1942.
مجله علوم پزشکی پارس